Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial
用户tAk0_GOpgUgo
3个月前
123
10
已完结
1. 系统已在2025-03-24 17:01:23对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s1474-4422(24)00436-8
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1474442224004368
其他信息:
出版社: Elsevier BV
作者: Shuya Li; Hong-Qiu Gu; Baoyu Feng; Hao Li; Xuechun Wang; Qiang Dong; Dongsheng Fan; Yun Xu; Suiqiang Zhu; Hongguo Dai; Yan Wei; Ziran Wang; Guozhi Lu; Yutong Ma; Zixiao Li; Yilong Wang; Xia Meng; Xingquan Zhao; Liping Liu; Yongjun Wang
